In:
Nephrology, Wiley, Vol. 20, No. 10 ( 2015-10), p. 721-726
Abstract:
This study highlights the challenges in developing better biomarkers for the assessment of disease progression in diabetic kidney disease. The cohort examines the role of serum spondin‐2 as a marker of disease progression diabetic nephropathy.
Type of Medium:
Online Resource
ISSN:
1320-5358
,
1440-1797
DOI:
10.1111/nep.2015.20.issue-10
Language:
English
Publisher:
Wiley
Publication Date:
2015
detail.hit.zdb_id:
2008235-6
Bookmarklink